Skip to main content
TipRanks
Go Ultimate75% OFF
GenrAb Inc logo

GenrAb Inc: Valuation, Funding & Investors

GenrAb Inc. is a biotechnology company focused on developing first-in-class neuroprotective therapies. The company is advancing its lead candidate, TGM-010, a fully-human neuroprotective antibody designed to cross the blood-brain barrier and engage neuronal stress management mechanisms to mitigate neurological disabilities. GenrAb is building a pipeline of innovative neurotherapeutic antibodies aimed at addressing unmet medical needs in neurology.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$6M
Total Funding Rounds
1
Latest Funding Amount
$6M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Apr 22, 2025Seed Round$5.60M―

Similar Companies

A snapshot of private companies similar to GenrAb Inc, helping you discover and navigate related company profiles.

Related News and Analysis